Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study.

Nikolaos P E KadoglouEmmanouil KorakasStylianos LampropoulosEirini MaratouGeorge KassimisNikolaos PatsourakosPanagiotis PlotasParaskevi MoutsatsouVaia A Lambadiari

Published in: Cardiovascular diabetology (2021)

Serum DPP4 levels are increased in patients with CAD, while serum nesfatin-1 levels have a negative association with both the incidence and the severity of CAD. These results are independent of the presence of diabetes mellitus. In addition, both peptides have a strong association with hsCRP. Trial registration ClinicalTrials.gov Identifier: NCT00306176.

Keyphrases

coronary artery disease
clinical trial
risk factors
study protocol
type diabetes
skeletal muscle
metabolic syndrome
insulin resistance
amino acid
open label